Senate committee schedules Nov. 18 vote on FDA nominee Heidi Overton

2 SOURCES UNITED STATESNEW

BLUF

The Senate health committee has scheduled a Nov. 18 vote on Dr. Heidi Overton’s nomination to lead the FDA. Her confirmation prospects remain uncertain, according to The Hill.

HOW THIS BRIEF WAS MADE 2 outlets: 2 national. Automated sourcing and summaries by the BLUF engine. Corrections

Why it matters

The vote is a step toward deciding who will lead the FDA, the agency responsible for regulating medicines and other products. The reports do not establish when the full Senate might act or whether Overton has enough support to advance.

What happens next

The Senate health committee is scheduled to vote on Nov. 18. The outcome and any later full-Senate vote are not yet known.

The committee’s Nov. 18 vote

Whether the nomination advances to a full Senate vote